thiopalmitoylated peptides (University of Queensland)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namethiopalmitoylated peptides (University of Queensland)
Drug Alias NameS-palm-APL (University of Queensland)Tolergentide
ClassificationSmall molecules > LipidSmall molecules > Synthetic peptide
Mechanisms of ActionImmunosuppressantsT lymphocytes modulators
TargetsUpdating
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniquest Pty LtdThe University Of Queensland
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A